home / stock / itos / itos news


ITOS News and Press, iTeos Therapeutics Inc.

Stock Information

Company Name: iTeos Therapeutics Inc.
Stock Symbol: ITOS
Market: NASDAQ
Website: iteostherapeutics.com

Menu

ITOS ITOS Quote ITOS Short ITOS News ITOS Articles ITOS Message Board
Get ITOS Alerts

News, Short Squeeze, Breakout and More Instantly...

ITOS - (ITOS) Technical Data

2024-05-22 01:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

ITOS - Merck discontinues testing of experimental skin cancer combo therapy

2024-05-13 07:58:54 ET Merck ( NYSE: MRK ) has discontinued the vibostolimab and pembrolizumab coformulation arm of a late-stage skin cancer trial .... Read the full article on Seeking Alpha For further details see: Merck discontinues testing of experimental skin...

ITOS - ITOS Price Target Alert: $46.00. Issued by H.C. Wainwright

2024-05-13 07:00:04 ET Swayampakula Ramakanth from H.C. Wainwright issued a price target of $46.00 for ITOS on 2024-05-13 06:11:00. The adjusted price target was set to $46.00. At the time of the announcement, ITOS was trading at $17.44. ITOS currently trades -32.51% ver...

ITOS - US Companies Moving the Markets, Evening edition
Fri, May 10, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Novavax Inc. (NVAX) rose 98.7% to $8.88 on volume of 168,692,127 shares AEye Inc. (LIDR) rose 115.0% to $2.58 on volume of 156,236,079 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) fell 17.3% to $0.7609 on volume of 123,678,040 s...

ITOS - NVAX, GRPN and MVIS among mid-day movers

2024-05-10 12:57:54 ET Gainers: Novavax NVAX +106% . AEye LIDR +67% . ITeos Therapeutics ITOS +48% . Sensus Healthcare SRTS +35% . Inseego Corp INSG +32% . Sweetgreen SG +33% . Organogenesis Holdings ORGO +33% . Caredx CDNA +32...

ITOS - iTeos Therapeutics signs agreement for $120M registered direct offering

2024-05-10 10:14:03 ET More on iTeos Therapeutics Seeking Alpha’s Quant Rating on iTeos Therapeutics Historical earnings data for iTeos Therapeutics Financial information for iTeos Therapeutics Read the full article on Seeking Alpha For further...

ITOS - US Companies Moving the Markets, Morning edition
Fri, May 10, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Novavax Inc. (NVAX) rose 128.7% to $10.225 on volume of 69,182,168 shares SoundHound AI Inc. (SOUN) rose 23.9% to $5.885 on volume of 25,153,154 shares Greenwave Technology Solutions Inc. (GWAV) fell 31.9% to $0.0476 on volume of 22,3...

ITOS - iTeos Therapeutics reports Q1 results

2024-05-10 09:48:34 ET More on iTeos Therapeutics Seeking Alpha’s Quant Rating on iTeos Therapeutics Historical earnings data for iTeos Therapeutics Financial information for iTeos Therapeutics Read the full article on Seeking Alpha For further...

ITOS - iTeos Therapeutics to raise $120 million via registered direct offering

2024-05-10 09:45:14 ET iTeos Therapeutics Inc (NASDAQ: ITOS) is up 30% today after announcing plans of a registered direct offering. iTeos Therapeutics stock pops on Q1 earnings The biotechnology company will sell a total of 1,142,857 shares at $17.50 each which translates to a ...

ITOS - iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates

- Belrestotug + dostarlimab exceeded pre-defined efficacy criteria for clinically relevant activity observed in an interim assessment of Phase 2 GALAXIES Lung-201 - Clinically meaningful tumor reduction observed at every belrestotug + dostarlimab dose vs monotherapy - GSK to provide u...

Next 10